Elevated mRNA or protein expression of HDAC5 led to an increased proliferation and invasiveness of a lung cancer cell line and was associated with inferior prognoses and clinical outcomes in patients with breast cancer and hepatocellular carcinoma [22,23,93,94]. This evidence concerns the gene HDAC5 and breast carcinoma.